BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 25350271)

  • 1. Immunolocalization of glioma-associated oncogene homolog 1 in non melanoma skin cancer.
    Bakry OA; Samaka RM; Shoeib MA; Megahed DM
    Ultrastruct Pathol; 2015 Apr; 39(2):135-46. PubMed ID: 25350271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical expression of sperm-associated antigen 9 in nonmelanoma skin cancer.
    Seleit I; Bakry OA; Samaka RM; Malak MA
    Am J Dermatopathol; 2015 Jan; 37(1):38-45. PubMed ID: 25033008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Aquaporin-3 Role in Nonmelanoma Skin Cancer: An Immunohistochemical Study.
    Seleit I; Bakry OA; Al Sharaky D; Ragheb E
    Ultrastruct Pathol; 2015; 39(5):306-17. PubMed ID: 26107428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GLUT-1 Expression in Cutaneous Basal and Squamous Cell Carcinomas.
    Abdou AG; Eldien MM; Elsakka D
    Int J Surg Pathol; 2015 Sep; 23(6):447-53. PubMed ID: 26092229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical galectin-3 expression in non-melanoma skin cancers.
    Kapucuoglu N; Basak PY; Bircan S; Sert S; Akkaya VB
    Pathol Res Pract; 2009; 205(2):97-103. PubMed ID: 18951731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical visualization of the signature of activated Hedgehog signaling pathway in cutaneous epithelial tumors.
    Tanese K; Emoto K; Kubota N; Fukuma M; Sakamoto M
    J Dermatol; 2018 Oct; 45(10):1181-1186. PubMed ID: 30035333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACE and ACE2 expression in normal and malignant skin lesions.
    Grzegrzolka J; Swiatko K; Pula B; Zamirska A; Olbromski M; Bieniek A; Szepietowski J; Rys J; Dziegiel P; Podhorska-Okolow M
    Folia Histochem Cytobiol; 2013; 51(3):232-8. PubMed ID: 24203630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential immunohistochemical expression of matrix metalloproteinase-10 (MMP-10) in non-melanoma skin cancers of the head and neck.
    Kadeh H; Saravani S; Heydari F; Shahraki S
    Pathol Res Pract; 2016 Oct; 212(10):867-871. PubMed ID: 27567711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective in situ protein expression profiles correlate with distinct phenotypes of basal cell carcinoma and squamous cell carcinoma of the skin.
    Stelkovics E; Kiszner G; Meggyeshazi N; Korom I; Varga E; Nemeth I; Molnar J; Marczinovits I; Krenacs T
    Histol Histopathol; 2013 Jul; 28(7):941-54. PubMed ID: 23446646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical expression of ezrin in cutaneous basal and squamous cell carcinomas.
    Abdou AG; Maraee AH; El-Sayed EM; Elnaidany NF
    Ann Diagn Pathol; 2011 Dec; 15(6):394-401. PubMed ID: 21849257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of CD10 and Bcl2 expression in distinguishing cutaneous basal cell carcinoma from squamous cell carcinoma and seborrheic keratosis.
    Gaballah MA; Ahmed RA
    Pathol Res Pract; 2015 Dec; 211(12):931-8. PubMed ID: 26573127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression and significance of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase in non-melanoma skin cancer].
    Fu XR; Zhang C; Chen CY; Zhang L; Wang LX; Wang BH; Liu XY; Zhang MZ
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):369-73. PubMed ID: 22883459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of promyelocytic leukaemia protein in Bowen's disease, skin squamous cell carcinoma and basal cell carcinoma].
    Wang Q; Ma H; Wang S; Ma Y; Zou X; Li R
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jul; 33(7):1075-7. PubMed ID: 23895857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteinase-activated receptor-2 expression in basal and squamous cell carcinomas compared with normal skin.
    Dastgheib L; Monabati A; Mohammadian A; Sari-Aslani F; Marzban S; Namazi MR
    J Cutan Pathol; 2009 Mar; 36(3):314-7. PubMed ID: 19032384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of RUNX3 in skin cancers.
    Lee JH; Pyon JK; Kim DW; Lee SH; Nam HS; Kang SG; Kim CH; Lee YJ; Chun JS; Cho MK
    Clin Exp Dermatol; 2011 Oct; 36(7):769-74. PubMed ID: 21623876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P16INK4a Immunostaining but Lack of Human Papilloma Virus Type 16 in Cutaneous Squamous Cell Carcinoma and Basal Cell Carcinoma: a Report from West Iran.
    Ramezani M; Abdali E; Khazaei S; Vaisi-Raygani A; Sadeghi M
    Asian Pac J Cancer Prev; 2016; 17(3):1093-6. PubMed ID: 27039730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular diagnosis of basal cell carcinoma and other basaloid cell neoplasms of the skin by the quantification of Gli1 transcript levels.
    Hatta N; Hirano T; Kimura T; Hashimoto K; Mehregan DR; Ansai S; Takehara K; Takata M
    J Cutan Pathol; 2005 Feb; 32(2):131-6. PubMed ID: 15606671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Podoplanin in Non-melanoma Skin Cancers and Actinic Keratosis.
    Wojciechowska-Zdrojowy M; Szepietowski JC; Matusiak Ł; Dzięgiel P; Puła B
    Anticancer Res; 2016 Apr; 36(4):1591-7. PubMed ID: 27069135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the PI3K/AKT signalling pathway in non-melanoma skin cancer is not mediated by oncogenic PIK3CA and AKT1 hotspot mutations.
    Hafner C; Landthaler M; Vogt T
    Exp Dermatol; 2010 Aug; 19(8):e222-7. PubMed ID: 20557351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of PC cell-derived growth factor and cyclin D1 expression in cutaneous squamous cell carcinoma.
    Huang K; Huang C; Shan K; Chen J; Li H
    Clin Exp Dermatol; 2012 Jun; 37(4):411-7. PubMed ID: 22420613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.